Characteristics | Discovery stage | Replication stage | ||
---|---|---|---|---|
 | Case | Control | Case | Control |
 | N = 622 | N = 8853 | N = 646 | N = 8810 |
Demographic characteristics | ||||
 Age, year, mean (SD) | 62 (19) | 59 (9) | 62 (15) | 59 (8) |
 Male, n (%) | 323 (52) | 4041 (46) | 341 (53) | 4041 (46) |
 BMI, kg/m2, mean (SD) | 24.4 (3.9) | - | 24.5 (3.6) | - |
 PE alone, n (%) | 331 (53) | - | 340 (53) | - |
 PE combined DVT, n (%) | 291 (47) | - | 306 (47) | - |
Complications and risk factors | Â | - | Â | - |
 Cardiovascular disease, n (%) | 311 (50) | - | 311 (48) | - |
 Chronic pulmonary disease, n (%) | 105 (17) | - | 118 (18) | - |
 Cancer, n (%) | 60 (10) | - | 62 (10) | - |
 Metabolic and endocrine diseases, n (%) | 108 (17) | - | 101 (16) | - |
 Smoking history, n (%) | 198 (32) | - | 182 (28) | - |
 | N = 218 |  | N = 220 |  |
Thrombophilia test | Â | - | Â | - |
 Plasma antithrombin activity < 70%, n/N (%) | 32 (15) | - | 32 (15) | - |
 Plasma protein S activity < 60%, n/N (%) | 36 (17) | - | 42 (19) | - |
 Plasma protein C activity < 70%, n/N, n/N (%) | 42 (19) | - | 49 (22) | - |